S. Lehto

V. Salomaa, M. Niemelä, J. Tuomilehto, 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease.

M. Laakso, M. Lehtonen, S. Lehto, 2001, Atherosclerosis.

Rationale, design, and organization of the metoprolol CR/XL randomized intervention trial in heart failure (MERIT-HF)

D. DeMets, B. Fagerberg, S. Ball, 1997 .

Serum cholesterol and high density lipoprotein cholesterol distributions in patients with acute myocardial infarction and in the general population of Kuopio Province, Eastern Finland

V. Salomaa, J. Tuomilehto, K. Pyörälä, 1993, Journal of internal medicine.

Variants of the Fatty Acid-Binding Protein 2 Gene Are Not Associated With Coronary Heart Disease in Nondiabetic Subjects and in Patients With NIDDM

M. Laakso, S. Heikkinen, S. Lehto, 1998, Diabetes Care.

Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease.

M. Laakso, M. Uusitupa, S. Lehto, 2002, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects.

M. Laakso, M. Laakso, S. Haffner, 1996, Stroke.

MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.

M. Laakso, S. Lehto, A. Kareinen, 2000, Diabetes care.

Dietary fat predicts coronary heart disease events in subjects with type 2 diabetes.

M. Laakso, S. Lehto, T. Rönnemaa, 2003, Diabetes care.

Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease.

M. Uusitupa, S. Lehto, S. Ylä-Herttuala, 2005, Atherosclerosis.

Trends in coronary events in Finland during 1983-1997. The FINAMI study.

V. Salomaa, M. Niemelä, J. Tuomilehto, 2003, European heart journal.

Improved survival of type 2 diabetic patients on renal replacement therapy in Finland.

S. Lehto, R. Ikäheimo, P. Finne, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women.

M. Laakso, S. Lehto, T. Rönnemaa, 2009, Atherosclerosis.

Type 2 diabetic patients on renal replacement therapy: Probability to receive renal transplantation and survival after transplantation

S. Lehto, P. Finne, C. Grönhagen-Riska, 2018, PloS one.

Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland.

T. Strandberg, S. Lehto, H. Oksa, 1997, European Heart Journal.

Potential for cholesterol lowering in secondary prevention of coronary heart disease in europe: findings from EUROASPIRE study. European Action on Secondary Prevention through Intervention to Reduce Events.

G. De Backer, D. De Bacquer, D. Bacquer, 2000, Atherosclerosis.

Decline in Out-of-Hospital Coronary Heart Disease Deaths Has Contributed the Main Part to the Overall Decline in Coronary Heart Disease Mortality Rates Among Persons 35 to 64 Years of Age in Finland: The FINAMI Study

V. Salomaa, M. Niemelä, J. Tuomilehto, 2003, Circulation.

Socioeconomic inequalities in the morbidity and mortality of acute coronary events in Finland: 1988 to 2002.

V. Salomaa, J. Airaksinen, S. Lehto, 2012, Annals of epidemiology.

Prognosis of acute coronary events is worse in patients living alone: the FINAMI myocardial infarction register

V. Salomaa, J. Airaksinen, S. Lehto, 2014, European journal of preventive cardiology.

Depression after coronary heart disease events.

M. Laakso, M. Laakso, S. Lehto, 2000, Scandinavian cardiovascular journal : SCJ.

The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points.

S. Lehto, L. Wallentin, T. Gundersen, 1999, European heart journal.

Discontinuation of dialysis treatment: Experience of a single dialysis centre

S. Lehto, O. Ryynänen, R. Ikäheimo, 2005, Scandinavian journal of urology and nephrology.

Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease

I. Vauhkonen, M. Laakso, S. Lehto, 2000, Journal of Molecular Medicine.

The codon 64 polymorphism of the beta3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients.

M. Laakso, S. Heikkinen, S. Lehto, 1999, Metabolism: clinical and experimental.

Coronary events in persons aged 75 years or older in Finland from 1995 to 2002: the FINAMI study.

V. Salomaa, A. Havulinna, S. Lehto, 2008, The American journal of geriatric cardiology.

High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men: A Population-Based 18-Year Follow-Up Study

M. Laakso, S. Lehto, T. Rönnemaa, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes.

M. Laakso, S. Lehto, A. Kareinen, 2000, Diabetes care.

Retinopathy Predicts Coronary Heart Disease Events in NIDDM Patients

M. Laakso, S. Haffner, H. Miettinen, 1996, Diabetes Care.

Bene ﬁ ts and Safety of Long-Term Feno ﬁ brate Therapy in People With Type 2 Diabetes and Renal Impairment The FIELD Study

Timothy, S. Lehto, J. Simes, 2012 .

Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: a controlled trial.

M. Uusitupa, S. Lehto, P. Soininen, 2014, Journal of clinical lipidology.

Potential for optimizing management of obesity in the secondary prevention of coronary heart disease.

E. Mirrakhimov, G. De Backer, D. De Bacquer, 2021, European heart journal. Quality of care & clinical outcomes.

Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease.

J. Hartikainen, M. Laakso, E. Vanninen, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland.

M. Laakso, P. Saikku, M. Laakso, 1996, European heart journal.

Catheter-directed thrombolysis of proximal lower extremity deep vein thrombosis: a prospective trial with venographic and clinical follow-up.

S. Lehto, H. Manninen, A. Juutilainen, 2012, European journal of radiology.

Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance.

M. Laakso, S. Lehto, 1997, Atherosclerosis.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Association between Chlamydia pneumoniae antibodies and intimal calcification in femoral arteries of nondiabetic patients.

L. Niskanen, M. Laakso, P. Saikku, 2002, Archives of internal medicine.

Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment

A. Keech, R. Simes, A. Jenkins, 2012, Diabetes Care.

Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?

M. Laakso, M. Laakso, S. Lehto, 1995, Diabetologia.

Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus.

M Suhonen, L. Niskanen, M. Laakso, 1996, Arteriosclerosis, thrombosis, and vascular biology.

n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.

M. Uusitupa, S. Lehto, A. Erkkilä, 2003, The American journal of clinical nutrition.

Cardiovascular event rate and death in high‐risk secondary prevention patient cohort in Finland: A registry study

J. Hartikainen, S. Lehto, J. Sinisalo, 2022, Clinical cardiology.

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

J. De Sutter, R. Peters, S. Wiedmann, 2019, Atherosclerosis.

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

Diederick Grobbee, Davor Milicic, Dirk De Bacquer, 2019, European journal of preventive cardiology.

Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy.

M. Laakso, S. Lehto, T. Rönnemaa, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes

M. Laakso, S. Lehto, T. Rönnemaa, 2000, Diabetologia.

Risk Factors Predicting Lower Extremity Amputations in Patients With NIDDM

M. Laakso, S. Lehto, T. Rönnemaa, 1996, Diabetes Care.

Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study

V. Salomaa, J. Tuomilehto, H. Miettinen, 2005, Diabetologia.

Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study.

V. Salomaa, M. Niemelä, J. Tuomilehto, 1996, Circulation.

Thoracoabdominal Calcifications Predict Cardiovascular Disease Mortality in Type 2 Diabetic and Nondiabetic Subjects

M. Laakso, S. Lehto, T. Rönnemaa, 2009, Diabetes Care.

Are coronary event rates declining slower in women than in men - evidence from two population-based myocardial infarction registers in Finland?

V. Salomaa, A. Havulinna, J. Airaksinen, 2007, BMC cardiovascular disorders.

Lipids and Lipoproteins Predicting Coronary Heart Disease Mortality and Morbidity in Patients With Non-insulin-dependent Diabetes

M. Laakso, S. Lehto, I. Penttilä, 1993 .

Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes Mellitus

M. Laakso, S. Lehto, J. Marniemi, 2004, Annals of Internal Medicine.

Physical Activity, High-Sensitivity C-Reactive Protein, and Total and Cardiovascular Disease Mortality in Type 2 Diabetes

M. Laakso, S. Lehto, T. Rönnemaa, 2011, Diabetes Care.

Impact off Diabetes on Mortality After the First Myocardial Infarction

V. Salomaa, J. Tuomilehto, S. Haffner, 2010 .

Sex differences in short- and long-term case-fatality of myocardial infarction

V. Salomaa, A. Havulinna, S. Lehto, 2011, European Journal of Epidemiology.

Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study

V. Salomaa, M. Niemelä, J. Tuomilehto, 2001, Journal of epidemiology and community health.

Long-term prognosis after coronary artery bypass surgery.

V. Salomaa, M. Niemelä, J. Tuomilehto, 2008, International journal of cardiology.

Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

Seppo Lehto, M. Laakso, S. Lehto, 2005, Diabetes care.

Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

M. Laakso, A. Keech, S. Lehto, 2010, European heart journal.

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys

D. Bacquer, U. Keil, S. Lehto, 2004, Diabetologia.

Gender difference in the impact of type 2 diabetes on coronary heart disease risk.

Seppo Lehto, M. Laakso, S. Lehto, 2004, Diabetes care.

Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes.

M. Laakso, S. Lehto, T. Rönnemaa, 1996, Stroke.

Heart rate variability associates with asymptomatic coronary atherosclerosis

J. Hartikainen, E. Vanninen, S. Lehto, 2014, Clinical Autonomic Research.

Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study.

V. Salomaa, M. Niemelä, J. Tuomilehto, 2000, Circulation.

Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease.

M. Uusitupa, S. Lehto, S. Ylä-Herttuala, 2000, Arteriosclerosis, thrombosis, and vascular biology.

The effect of fatty or lean fish intake on inflammatory gene expression in peripheral blood mononuclear cells of patients with coronary heart disease

M. Uusitupa, M. Orešič, S. Lehto, 2009, European journal of nutrition.

Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications

M. Uusitupa, S. Lehto, U. Schwab, 2008, European journal of nutrition.

Fatty Fish Intake Decreases Lipids Related to Inflammation and Insulin Signaling—A Lipidomics Approach

Matej Orešič, Tuulikki Seppänen-Laakso, Seppo Lehto, 2009, PloS one.

Gender differences in the prevalence, causes and treatment of high cardiovascular risk: findings from the FINRISK Survey

V. Salomaa, A. Havulinna, P. Jousilahti, 2012, European journal of preventive cardiology.

Trends in long-term prognosis after acute coronary syndrome

V. Salomaa, H. Huikuri, A. Havulinna, 2017, European journal of preventive cardiology.

High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study.

M. Laakso, S. Lehto, T. Rönnemaa, 2006, Diabetes care.

Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future

V. Salomaa, A. Havulinna, J. Airaksinen, 2013, Heart.

Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE risk categories.

G. De Backer, J. Deckers, D. De Bacquer, 2013, International journal of cardiology.

Does the clinical spectrum of incident cardiovascular disease differ between men and women?

V. Salomaa, A. Havulinna, S. Lehto, 2014, European journal of preventive cardiology.

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

J. De Sutter, P. Heuschmann, J. Tuomilehto, 2015, Cardiovascular Diabetology.

Acute myocardial infarction (AMI) in Finland--baseline data from the FINMONICA AMI register in 1983-1985.

V. Salomaa, J. Tuomilehto, P. Puska, 1992, European heart journal.

Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.

J. De Sutter, P. Amouyel, G. De Backer, 2017, Global heart.

Effect of Vascular Comorbidities on Survival of Type 2 Diabetes Patients on Renal Replacement Therapy

S. Lehto, P. Finne, Marjo H Kervinen, 2012, American Journal of Nephrology.

Serum homocysteine, creatinine, and glucose as predictors of the severity and extent of coronary artery disease in asymptomatic members of high‐risk families

M. Laakso, M. Nieminen, S. Lehto, 2002, European journal of clinical investigation.

Proteinuria modifies the effect of systolic blood pressure on total and cardiovascular disease mortality in patients with type 2 diabetes

M. Laakso, S. Lehto, T. Rönnemaa, 2012, Journal of internal medicine.

Diet in relation to socioeconomic status in patients with coronary heart disease

M. Uusitupa, S. Lehto, E. Sarkkinen, 1999, European Journal of Clinical Nutrition.

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from twenty four European countries

Dragan, Lale, P. Heuschmann, 2016 .

Diagnosis of acute myocardial infarction by MONICA and FINMONICA diagnostic criteria in comparison with hospital discharge diagnosis.

J. Tuomilehto, H. Miettinen, S. Lehto, 1994, Journal of clinical epidemiology.

Case fatality of acute coronary events is improving even among elderly patients; the FINAMI study 1995–2012

V. Salomaa, A. Havulinna, J. Airaksinen, 2018, Annals of medicine.

Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women

Seppo Lehto, M. Laakso, S. Lehto, 2007, Diabetes Care.

Lens opacity in patients with hypercholesterolemia and ischaemic heart disease

S. Lehto, A. Rantala, K. Pyörälä, 1992, Documenta Ophthalmologica.

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome

V. Salomaa, H. Huikuri, A. Havulinna, 2021, Annals of medicine.

Contents Vol. 36, 2012

M. Fischer, F. Pieruzzi, M. Schnitzler, 2012, American Journal of Nephrology.

Are coronary event rates declining slower in women than in men – evidence from two population-based myocardial infarction registers in Finland?

V. Salomaa, A. Havulinna, J. Airaksinen, 2007 .

Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients.

J. De Sutter, P. Amouyel, G. De Backer, 2015, Journal of the American College of Cardiology.

Cardiovascular Risk Factors Associated With Insulin Resistance Cluster in Families With Early-Onset Coronary Heart Disease

M. Laakso, S. Lehto, A. Kareinen, 2001, Arteriosclerosis, thrombosis, and vascular biology.